MT-202

N/A

Report date: 2025/02/14 15:13:52

Base Information

Drug NameMT-202
Drug Alias NameMT-202
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTEK receptor tyrosine kinase agonists
TargetsTEK receptor tyrosine kinase
Therapy Area/IndicationsMyocardial InfarctionStrokePulmonary Embolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMaptics Corp
China Registration ClassN/A

Develop Information

Active CompaniesCuracle Co Ltd
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionStrokePulmonary Embolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A